Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YKYY032 in Adults With Hyperlipoproteinemia (a)
NCT07914660Phase 2Not yet recruiting
- Sponsor
- Yuekang Pharmaceutical
- Start
- Nov 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of YKYY032 in Hyperlipoproteinemia a, sponsored by Yuekang Pharmaceutical. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
YKYY032
03
Conditions
Hyperlipoproteinemia a
Beyond the preview
Go deeper on NCT07914660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914660.